Our Take
This section will present ‘Our Take’ on important health related topics, news, industry changes, and to voice our proposals and opinions on radical changes in healthcare. We will remain in the public eye through features like the Health Revival ‘What If?’ Series the Audacious Truth of the Week Series, OP ED’s on controversial changes or conditions, The State of Medicine Today, Guest Interviews and eventually a podcasts series on relevant Revival topics
Currently, FDA approval for chronic disease medications often relies on short-term symptom-based endpoints without requiring evidence of disease prevention or reversal. Our proposal is to reframe approval standards to prioritize long-term patient outcomes.
America’s chronic disease epidemic is isolating millions. A diagnosis often marks the beginning of a long and lonely journey. But what if recovery didn’t have to happen alone between visits? What if we treated chronic disease recovery like we treat addiction recovery?
The average American sees 9 drug ads a day, with over $8 billion spent annually by pharmaceutical companies to market chronic disease medications that often manage rather than reverse conditions. What if pharmaceutical ads partially funded alternative, effective approaches to treating chronic disease?
In a future reshaped by AI, where traditional jobs are increasingly automated, the value of staying healthy is no longer just personal—it is becoming economic. Imagine a national program where individuals can earn supplemental income and receive insurance discounts by achieving and maintaining verifiable health improvements.
What if HHS inspired a national competition to reverse community chronic disease? Communities would compete not just for bragging rights, but to restore vitality, extend life expectancy, and dramatically reduce the burden of preventable chronic illness.
The U.S. healthcare system is structurally misaligned with the needs of the 21st century. Chronic diseases consume over 80% of healthcare costs, while the system remains optimized for acute care, diagnostics, and pharmaceutical interventions. Proposal: Provide clinics incentives to shift toward preventing and reversing chronic disease through evidence-informed integrative therapies.
Imagine participating in the launch of a national AI-enabled
medical association dedicated to the restoration of American Health. What if HHS partnered with the top dozen alternative medicine organizations to create a powerful coalition rooted in science, outcomes, and shared purpose?
Did you know there’s a way to actually beat chronic disease with lifestyle changes? What if we documented the slowing, halting, or reversal of chronic disease in 200,000 patients by July 4, 2027? That’s the vision of the “200K in 2” Skeptics Reduction Program. Let’s Scale What Already Works
What if the first-line treatment for depression wasn’t a prescription, but a health evaluation and a meal plan? The U.S. is on the brink of a psychiatric health crisis, and it’s time we use every tool available—especially the fork.
What if becoming healthier was not only encouraged but certifiable…beginning with the very people responsible for shaping public health?